Literature DB >> 9182540

Two activation states of the prohormone convertase PC1 in the secretory pathway.

I Jutras1, N G Seidah, T L Reudelhuber, V Brechler.   

Abstract

PC1, a neuroendocrine member of the prohormone convertase family of serine proteinases, is implicated in the processing of proproteins in the secretory pathway. PC1 is synthesized as a zymogen and cleaves not only its own profragment in the endoplasmic reticulum, but a subset of protein substrates in the Golgi apparatus and in the Golgi-distal compartments of the regulated secretory pathway. Likewise, mouse PC1 (mPC1) has previously been shown to cleave human prorenin in GH4 cells (that contain secretory granules) while being unable to cleave prorenin in cells, such as Chinese hamster ovary (CHO) or BSC-40, which are devoid of secretory granules. In the current study, we show that removal of a C-terminal tail of mPC1 allows the efficient cleavage of prorenin in the constitutive secretory pathway of CHO cells. The C-terminal tail thus appears to act as an inhibitor of PC1 activity against certain substrates in the endoplasmic reticulum and Golgi apparatus, and its removal, which occurs naturally in secretory granules, may explain the observed granule-specific processing of certain proproteins. These results also demonstrate that PC1 is present in a partially active state prior to the secretory granules where it is processed to a maximally active state.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9182540     DOI: 10.1074/jbc.272.24.15184

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Inhibition of prohormone convertases PC1/3 and PC2 by 2,5-dideoxystreptamine derivatives.

Authors:  Mirella Vivoli; Thomas R Caulfield; Karina Martínez-Mayorga; Alan T Johnson; Guan-Sheng Jiao; Iris Lindberg
Journal:  Mol Pharmacol       Date:  2011-12-14       Impact factor: 4.436

2.  The transmembrane domain of the prohormone convertase PC3: a key motif for targeting to the regulated secretory pathway.

Authors:  Hong Lou; Angela M Smith; Leigh C Coates; Niamh X Cawley; Y Peng Loh; Nigel P Birch
Journal:  Mol Cell Endocrinol       Date:  2006-12-16       Impact factor: 4.102

Review 3.  Sorting and storage during secretory granule biogenesis: looking backward and looking forward.

Authors:  P Arvan; D Castle
Journal:  Biochem J       Date:  1998-06-15       Impact factor: 3.857

Review 4.  Insights from bacterial subtilases into the mechanisms of intramolecular chaperone-mediated activation of furin.

Authors:  Ujwal Shinde; Gary Thomas
Journal:  Methods Mol Biol       Date:  2011

5.  Dynamic palmitoylation of lymphoma proprotein convertase prolongs its half-life, but is not essential for trans-Golgi network localization.

Authors:  J W van de Loo; M Teuchert; I Pauli; E Plets; W J Van de Ven; J W Creemers
Journal:  Biochem J       Date:  2000-12-15       Impact factor: 3.857

Review 6.  POMC: The Physiological Power of Hormone Processing.

Authors:  Erika Harno; Thanuja Gali Ramamoorthy; Anthony P Coll; Anne White
Journal:  Physiol Rev       Date:  2018-10-01       Impact factor: 37.312

7.  Proinsulin endoproteolysis confers enhanced targeting of processed insulin to the regulated secretory pathway.

Authors:  R Kuliawat; D Prabakaran; P Arvan
Journal:  Mol Biol Cell       Date:  2000-06       Impact factor: 4.138

8.  Mutational analysis of predicted interactions between the catalytic and P domains of prohormone convertase 3 (PC3/PC1).

Authors:  Kazuya Ueda; Gregory M Lipkind; An Zhou; Xiaorong Zhu; Andrey Kuznetsov; Louis Philipson; Paul Gardner; Chunling Zhang; Donald F Steiner
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-29       Impact factor: 11.205

Review 9.  Proprotein convertases in tumor progression and malignancy: novel targets in cancer therapy.

Authors:  Abdel-Majid Khatib; Géraldine Siegfried; Michel Chrétien; Peter Metrakos; Nabil G Seidah
Journal:  Am J Pathol       Date:  2002-06       Impact factor: 4.307

10.  The collecting duct is the major source of prorenin in diabetes.

Authors:  Jung J Kang; Ildikó Toma; Arnold Sipos; Elliott J Meer; Sarah L Vargas; János Peti-Peterdi
Journal:  Hypertension       Date:  2008-04-14       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.